Pacific Biosciences Of California (PACB) EBT Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Pacific Biosciences Of California (PACB) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 30.00 |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 617.00 |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 258.00 |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | -646.00 |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | -82.00 |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 2,922.00 |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 1,974.00 |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | -305.00 |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | -3,374.00 |
| 10 | Pacific Biosciences Of California | 400.74 Mn | 163.87 Mn | 12.64 Mn | -920.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -920.00 |
| Mar 31, 2026 | 112,586.00 |
| Dec 31, 2025 | -9,682.00 |
| Sep 30, 2025 | 5,408.00 |
| Jun 30, 2025 | 37,591.00 |
| Mar 31, 2025 | -94,619.00 |
| Dec 31, 2024 | 14,863.00 |
| Sep 30, 2024 | -1,264.00 |
| Jun 30, 2024 | -33,448.00 |
| Mar 31, 2024 | 2,482.00 |
| Dec 31, 2023 | 16,672.00 |
| Sep 30, 2023 | 9,892.00 |
| Jun 30, 2023 | 5,451.00 |
| Mar 31, 2023 | 1,942.00 |
| Dec 31, 2022 | -11,928.00 |
| Jun 30, 2022 | -6,682.00 |
| Mar 31, 2022 | -12,326.00 |
| Dec 31, 2021 | -46,536.00 |
| Jun 30, 2021 | 328.00 |
| Mar 31, 2021 | 8,899.00 |